Northwell Health and START leaders are joined by local elected officials to celebrate the launch of the new centre. Credit: Northwell Health.

Northwell Health and the START Center for Cancer Research have inaugurated a $5.7mearly-phase cancer clinical trial centre in the US.

The Northwell-START New York-Long Island facility is situated in Lake Success and is part of the R.J. Zuckerberg Cancer Center, which hosts Northwell specialists and offers infusion therapy, imaging services, and radiation therapy.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

It represents START’s inaugural site in New York and builds on an alliance formed between the two firms last year.

The facility is designed to deliver early-phase trials in a dedicated setting, allowing patients to receive cancer care treatment.

It is equipped with a research team, six private exam rooms, 14 infusion bays, a pharmacokinetic lab, and a pharmacy.

Situated within the same building as a diagnostic imaging centre, molecular testing laboratory, and procedural suites for biopsy, the centre provides access to a range of support services and medical specialities.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Northwell Cancer Institute executive director and physician-in-chief Richard Barakat said: “As a health system treating more New Yorkers with cancer than anyone else, we have both the responsibility and the opportunity to give our patients access to cutting-edge treatments without requiring them to travel far from home.”

The centre will be spearheaded by Northwell START New York-Long Island system head and the START Center for Cancer Research principal investigator Geraldine O’Sullivan Coyne.

The START network currently supports more than 800 active industry-sponsored early-phase cancer trials worldwide, and the Northwell site will be fully integrated into this network.

A second Northwell-START Center is planned for Manhattan, with an expected opening in 2027.

In 2024, START entered a strategic collaboration with Spain’s Fundación Rioja Salud to broaden access to early-phase cancer trials in La Rioja.

Clinical Trials Arena Excellence Awards - Nominations Closed

Nominations are now closed for the Clinical Trials Arena Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact.

Excellence in Action
Recognised with 2025 Excellence Awards for Research and Development and Marketing , Novotech converted FDA/EMA fast track designations into faster HDV trial timelines while translating complex HBV science into sponsor ready insights. Discover how this dual strength in execution and communication is reshaping liver disease clinical development.

Discover the Impact